ELV250117C780000
- 0.35
- 0.000.00%
Elevance Health Newsroom
Does Elevance Health (NYSE:ELV) Have A Healthy Balance Sheet?
Press Release: Elevance Health to Hold Conference Call and Webcast to Discuss Fourth Quarter and Full Year 2024 Results on January 23, 2025
Elevance Health, Inc. (ELV): A Bull Case Theory
Is Now An Opportune Moment To Examine Elevance Health, Inc. (NYSE:ELV)?
Healthcare Executives Bullish on 2025: But Why Are Stocks Slipping?
Elevance Health Is Maintained at Buy by Truist Securities
Truist Financial Maintains Elevance Health(ELV.US) With Buy Rating, Cuts Target Price to $480
Elevance Health Analyst Ratings
Express News | Elevance Health : Truist Securities Cuts Target Price to $480 From $520
U.S. Healthcare Execs Turn More Bullish for 2025: Deloitte
After experiencing a bumper harvest in 2024, the USA ETF may encounter setbacks this year.
The USA Exchange Traded Fund (ETF) received a record inflow of $1.1 trillion in 2024, but entering 2025, rapid growth may face more obstacles.
Investors in Elevance Health (NYSE:ELV) Have Seen Respectable Returns of 31% Over the Past Five Years
Elevance Health, Inc. (ELV): Among the Cheap Healthcare Stocks to Buy Heading Into 2025
Is Weakness In Elevance Health, Inc. (NYSE:ELV) Stock A Sign That The Market Could Be Wrong Given Its Strong Financial Prospects?
Today's Analyst Rating | Netflix Price Target Raised to $1000 by KeyBanc, Mizuho Securities Cuts Its Price Target Cut on Elevance Health to $455
Dec 24, Wall Street analysts have updated their stock ratings today including $Netflix(NFLX.US)$ and $Elevance Health(ELV.US)$.
Buckle up! Goldman Sachs: Market optimism is nearing its peak, Bullish on two defensive Sectors.
①Goldman Sachs advises investors to take more "defensive measures" as Wall Street's optimism about the USA economy and stock market approaches historical highs. ②Goldman Sachs' model is bullish on the performance of defensive stocks such as utilities and Medical Care.
Mizuho Securities Maintains Elevance Health(ELV.US) With Buy Rating, Cuts Target Price to $455
Mizuho Adjusts Price Target on Elevance Health to $455 From $505, Keeps Outperform Rating
Elevance Health Stock Plunges 29.6% in Q4: Buy, Hold or Sell?
U.S. Healthcare Spending Climbs 7.5% in 2023